bortezomib
Bortezomib was approved for medical use in the United States in 2003 and in Europe in 2004. Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.. Reference standards of Bortezomib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => 1-Bromo-2-methylpropane
[catalogue_number] => PA 02 79510
[category_ids] => ,92,84,
[chemical_name] =>
[weight] => 137.02
[form] => C4H9Br
[cas] => 78-77-3
[pslug] => 78-77-3-1-bromo-2-methylpropane-pa0279510
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 02 79510
Molecular Formula : C4H9Br
Molecular Weight : 137.02
stdClass Object
(
[pname] => (1S)-(1S,2S,3R,5S)-Pinanediol-1-ammoniumtrifluoroacetate-3-methylbutane-1-boronate
[catalogue_number] => PA 02 79520
[category_ids] => ,84,
[chemical_name] =>
[weight] => 379.22
[form] => C17H29BF3NO4
[cas] => 477254-69-6
[pslug] => 477254-69-6-1s-1s-2s-3r-5s-pinanediol-1-ammoniumtrifluoroacetate-3-methylbutane-1-boronate-pa0279520
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(1S)-(1S,2S,3R,5S)-Pinanediol-1-ammoniumtrifluoroacetate-3-methylbutane-1-boronate
Catalogue No.:PA 02 79520
Molecular Formula : C17H29BF3NO4
Molecular Weight : 379.22
